DESCRIPTION: (Adapted from Applicant's Abstract). The long term goal of
the proposed study is to determine whether testing for oncogenic types of
HPV should be used, either in conjunction with, or in place of cytology, for
screening women to detect CIN 2-3. Specifically, the sensitivity and
positive predictive value of different screening strategies for identifying
women with CIN 2-3 will be determined. Strategies include: 1) a single or
repeated abnormal Pap smear; 2) a single or repeated positive assay for
oncogenic HPV types; 3) one abnormal Pap smear (detected after re-screening
all cytologically negative smears from HPV DNA positive women); 4) one
abnormal Pap smear and one positive HPV DNA assay (in parallel or in
series); and 5) detection of oncogenic types of HPV DNA in urine. Current
studies examining the etiology of CIN 2-3 versus CIN 1 will be continued.
The study will test the hypothesis that among women with cervical HPV 16
infection, the type of infecting HPV variant, as well as characteristics of
the infected epithelial cells (i.e, immature and proliferating cells versus
mature and non proliferating cells) are associated with histologic changes
consistent with CIN 2-3 versus CIN 1. The screening and histopathology data
will be used in conjunction with information from the literature, the
NCI-sponsored Survival, Epidemiology, and End Results (SEER) Program,
Medicare and Medicaid databases, and community physicians to evaluate the
cost effectiveness of different approaches to cervical cancer control. The
proposed studies are intended to contribute to understanding of the
pathogenesis of cervical caner and to have important public health
implications for cervical cancer control.
Error Notice
The database may currently be offline for maintenance and should be operational soon. If not, we have been notified of this error and will be reviewing it shortly.
We apologize for the inconvenience.
- The DCCPS Team.